[Use of antilymphocyte globulin in the treatment of rheumatoid arthritis].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000906:Antibodies / Q000008:administration & dosage*; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D006736:Horses / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007136:Immunoglobulins / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D000961:Antilymphocyte Serum; D007106:Immune Sera; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D011241:Prednisone
Impiego della globulina antilinfocitaria nel trattamento dell'artrite reumatoide.